Palo Alto Investors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Sell |
1,246,033
-173,435
| -12% | -$401K | 0.61% | 25 |
|
|
2025
Q1 | $1.97M | Buy |
1,419,468
+608,200
| +75% | +$845K | 0.38% | 29 |
|
|
2024
Q4 | $1.4M | Hold |
811,268
| – | – | 0.22% | 33 |
|
|
2024
Q3 | $1.63M | Hold |
811,268
| – | – | 0.21% | 31 |
|
|
2024
Q2 | $1.82M | Hold |
811,268
| – | – | 0.21% | 31 |
|
|
2024
Q1 | $2.33M | Buy |
811,268
+281,407
| +53% | +$808K | 0.26% | 30 |
|
|
2023
Q4 | $938K | Buy |
+529,861
| New | +$938K | 0.08% | 31 |
|